Gilead’s lenacapavir: HIV prospects strongest in long-acting …
WEBAug 25, 2021 · Gilead’s lenacapavir will find its strongest niche as a long-acting HIV combination treatment, experts said. Manasi Vaidya August 25, 2021. Gilead announced a collaboration with Merck in March to study lenacapavir with islatravir, a nucleoside reverse transcriptase translocation inhibitor (NRTTI), which is also a new drug class in HIV.
Home - Clinical Trials Arena
WEBModerna blamed after children offered £1,500 to take part in Covid-19 trial. Under the EU Clinical Trials Regulation, financial incentives are not allowed for participants under 16 to prevent undue influence. More themes. Artificial Intelligence. Cloud.
Mounjaro (tirzepatide) for the Treatment of Type 2 Diabetes, USA
WEBJun 19, 2024 · Mounjaro ™ (tirzepatide) is a dual-targeted, injectable, sustained-release therapy indicated for the treatment of type 2 diabetes (T2D) in adults as an adjunct to diet and exercise.. Developed by Eli Lilly, a pharmaceutical company based in the US, Mounjaro is the first and only once-weekly glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor ...
Altasciences completes acquisition of US-based CRO WCCT Global
WEBFeb 19, 2021 · Altasciences noted that the acquisition will complement its current clinical operations in Montreal, Canada, and Kansas City, US. WCCT’s facility lies within close access to Altasciences’ preclinical facility in the state of Washington. Altasciences co-chief operating officer Steve Mason said: “This acquisition expands Altasciences ...
Novo Nordisk launches trial of pipeline drug CagriSema versus …
WEBNov 17, 2023 · Novo Nordisk launches trial of pipeline drug CagriSema versus newly approved Zepbound. The launch of this Phase III comparative trial by Novo Nordisk might imply that CagriSema and Zepbound are expected to become direct competitors once Novo Nordisk’s candidate reaches the market.
Prolia (Denosumab) - Therapy for Prevention and Treatment of ...
WEBAug 14, 2006 · Osteoporosis increases in later life, particularly in post-menopausal women, as bone density decreases. Amgen’s prolia (denosumab) is a biological therapy developed for the prevention and treatment of osteoporosis and other disorders characterised by bone loss. These include postmenopausal osteoporosis, rheumatoid arthritis, and cancer ...
Erbitux (Cetuximab) - Clinical Trials Arena
WEBJun 24, 2003 · Erbitux is a chimaeric monoclonal antibody (MAb) specific for the EGFR. Erbitux has been approved for use in metastatic colorectal cancer in both Switzerland and the US. In July 2002, ImClone Systems secured FDA approval for the production of Erbitux for use in clinical studies. One of several new cancer biotherapies, Erbitux is currently in ...
Axcella previews long Covid registrational trial plans in UK and US
WEBAug 2, 2022 · Axcella Therapeutics is in discussions with the UK Medicines and Healthcare products Regulatory Agency (MHRA) to run a registrational trial of AXA1125 in long Covid-19, CEO Bill Hinshaw says. The biotech plans to initiate regulatory conversations with the US Food and Drug Administration (FDA) in the “near term”, he tells Clinical Trials Arena.
Obesity: Six trials to watch over the next 12 months
WEBJun 30, 2023 · According to a report by GlobalData, the market for obesity drugs is predicted to be worth $37.1bn in 2031. GlobalData is a parent company of the Clinical Trials Arena. As more trials take place globally, not only will this help to provide a wider range of treatments for patients but will also assist the unmet need of lack of supply.
Phase 0 clinical trials: what you need to know
WEBJul 21, 2022 · Clinical Trials Arena breaks down the two most common types of Phase 0 trials, including window of opportunity trials in neuro-oncology. William Newton July 21, 2022. When the FDA introduced Phase 0 trials in 2006, the goal was to learn more about new drugs without exposing subjects to their full, potentially toxic, effects.